… termed ‘the HIV-associated lipodystrophy syndrome’ and of … individuals (patients with impaired
fasting glucose or glucose … the incidence and prevalence of dyslipidemia in the context of …

… compared to children without clinical signs of lipodystrophy, including short …
Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIVassociated facial …

… association of HAL with dyslipidemia and its management represent an … Hypoadiponectinemia,
dyslipidemia, and impaired growth in children with HIV-associated facial lipoatrophy…

… have dyslipidemia, impaired glucose … dyslipidemia and lipodystrophy than in healthy subjects
8. Hyperglycemia-hyperinsulinemia and conditions that favor hepatic lipogenesis increase …

… stress and macrophage infiltration, as well as altered adipocyte function and mitochondrial
toxicity, have been shown to be central to the development of HALS. The adipocyte, therefore, …

… in a patient with HIV-associated lipodystrophy syndrome. e | … The goals of dyslipidemia
treatment in lipodystrophy should … Hypoadiponectinemia is associated with insulin resistance, …

… but may be related to altered lipid metabolism within preadipocytes … resistance and
dyslipidemia may increase the identification … to be low in HIV-associated lipodystrophy, as in other …

… Leptin replacement dramatically improved dyslipidemia and … This process involves impairment
of both adipocyte … Recombinant human growth hormone to treat HIV-associated adipose …

… This kind of approach resulted to prevent HAART-related dyslipidemia and lipodystrophy. …
Bone mineral accrual of HAART-treated children is impaired in comparison to healthy children […

… Increased expression of TNF-α, IL-6, and IL-8 in HIV-associated lipodystrophy. Implications
for the reduced expression and plasma levels of adiponectin. American Journal of Physiology…